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Central role of nuclear transport in signalling, viral infection and developmentsica Acta-Molecular Cell RThat proteins have nuclear targeting signals that govern their nuclear
localization has been known for a number of years now, with much
important fundamental work having been performed since into
describing the basic cellular machinery for signal-dependent transport
into and out of the nucleus. Progress has nowbegun in characterising the
nature of the targeting signals and cargoes for transporters of the
importin (karyopherin) superfamily other than importin α/β and
importin β1, and the question of the roles of speciﬁc importins/importin
α forms in developmental pathways and cell fate determination.
Understanding of the nuclear transport pathways exploited by viruses
in infectedcells, and the importance thereof in infection is also advancing.
This special issue provides a state-of-the art insight into the basic
mechanics of nuclear transport in terms of the players, targeting
signals, regulatory mechanisms and important kinetic parameters.
Importantly, it also elaborates on current knowledge with respect to
the integral role of nuclear protein import, in regulation of signal
transduction (short term responses to signals), cellular fate (longer
term responses) in development/cell differentiation (e.g. myogenesis
and spermatogenesis), and during viral infection, including viral
evasion of the host immune response. The review chapters are
testimony to the importance of nuclear protein import in a whole
range of physiological processes and systems.0167-4889/$ – see front matter © 2010 Published by Elsevier B.V.
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